In recent studies, it has been proved that the reduction of insulin receptor substrate 1 (IRS-1) and Kinase B (PKB/Akt) plays a vital role regarding the origin pathomechanism of insulin resistance in patients with HCV is concerned. Here, IRS1 is linked to Insulin resistance.